BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22154286)

  • 1. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
    Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
    Song I; Kim CK; Park BK; Park W
    AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
    Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
    Kim CK; Park BK; Lee HM
    J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
    Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
    Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
    Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer.
    Kim AY; Kim CK; Park SY; Park BK
    AJR Am J Roentgenol; 2014 Dec; 203(6):W645-50. PubMed ID: 25415730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
    Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
    Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI and PSA correlations in patients with prostate cancer treated with radiation and hormonal therapy.
    Iraha Y; Murayama S; Kamiya A; Iraha S; Ogawa K
    Anticancer Res; 2012 Oct; 32(10):4467-71. PubMed ID: 23060574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
    J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
    Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
    Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases.
    Ren J; Huan Y; Wang H; Zhao H; Ge Y; Chang Y; Liu Y
    Abdom Imaging; 2008; 33(6):724-8. PubMed ID: 18219519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor magnetic resonance imaging of prostate cancer.
    Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
    Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: preliminary experience.
    Park SY; Kim CK; Park BK; Kwon GY
    AJR Am J Roentgenol; 2014 Sep; 203(3):W287-94. PubMed ID: 25148186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    Kim CK; Park BK; Kim B
    AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
    Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
    Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.